THE CLINICAL AND GENETIC PARALLELS OF VITAMIN D PROVISION AND BENIGN BREAST DISEASES
- Авторлар: Maltseva L.I.1, Garifullova Y.V.1, Kravtsova O.A.1
-
Мекемелер:
- Шығарылым: № 1 (2018)
- Беттер: 91-95
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248196
- ID: 248196
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Larisa Maltseva
Email: laramalc@mail.ru
Doctor of Medicine, Professor, Head of Department of Obstetrics and Gynecology № 1, Kazan State Medical Academy. 420012, Russia, Kazan, Butlerova str. 36
Yulia Garifullova
Email: gamil.garifullov@yandex.ru
PhD, Assistant of the Department of Obstetrics and Gynecology № 1, Kazan State Medical University. 420012, Russia, Kazan, Butlerova str. 49
Olga Kravtsova
Email: okravz@yandex.ru
PhD, Senior lecturer, Department of Biochemistry and Biotechnology, Institute of Fundamental Medicine and Biology, Kazan Federal University. 420008, Russia, Kazan, Kremlevskaya str. 18
Әдебиет тізімі
- Morrow M., Schnitt S.J., Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat. Rev. Clin. Oncol. 2015; 12(4): 227-38.
- Socolov D., Anghelache I., Ilea C., Socolov R., Carauleanu A. Benign breast disease and the risk of breast cancer in the next 15 years. Rev. Med. Chir. Soc. Med. Nat. Iasi. 2015; 119(1): 135-40.
- Dyrstad S.W., Yan Y., Eowler A.M., Colditz G.A. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res. Treat. 2015; 149(3): 569-75.
- Eliassen A.H., Warner E.T., Rosner B., Collins L.C., Beck A.H., Quintana L.M. et al. Plasma 25 hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res. 2016; 76(18): 5423-30.
- Rejnmarka L., Tietzeb A., Vestergaarda P., Buhlc L., Lehbrinkb M., Heickendorffd L. et al. Reduced pre-diagnostic 25-hydroxyvitamin D levels in women with breast cancer. Bone. 2009; 44: S162-7.
- Brian L., Sprague A., Trentham-Dietz R.E., Gangnon D.S., Buist M. et al. The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res. Treat. 2012; 131(1): 255-65.
- Zhang Z., He J.W., Eu W.Z., Zhang C.Q., Zhang Z.L. An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. J. Bone Miner. Res. 2013; 28(8): 1784-92.
- Anderson L.N., Cotterchio M., Knight J.A., Borgida A., Gallinger S., Cleary S.P. Genetic variants in vitamin D pathway genes and risk of pancreas cancer; results from a population-based case-control ctudy in Ontario, Canada. PLoS One. 2013; 8(6): e66768. doi: 10.1371/journal.pone.0066768.
- Ahn J., Yu K., Stolzenberg-Solomon R., Simon K.C., McCullough M.L., Gallicchio L. et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010; 19(13): 2739-2745.
- Lopes N., Sousa B., Martins D., Gomes M., Vieira D., Veronese L.A. et al. Alterations in vitamin D signaling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer. 2010; 10: 483-92.
- Jeong Y., Swami S., Krishnan A.V., Williams J.D., Martin S., Horst R.L. et al. Inhibition of mouse breast tumor initiating cells by calcitriol and dietary vitamin D. Mol. Cancer Ther. 2015; 14(8): 1951-61.